- Home
- THAR vs AYRO Comparison
THAR vs AYRO Comparison
Compare THAR & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- AYRO
- Stock Information
- Founded
- THAR 2017
- AYRO 2017
- Country
- THAR United States
- AYRO United States
- Employees
- THAR N/A
- AYRO N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- AYRO Telecommunications Equipment
- Sector
- THAR Health Care
- AYRO Consumer Discretionary
- Exchange
- THAR Nasdaq
- AYRO Nasdaq
- Market Cap
- THAR 4.0M
- AYRO 4.8M
- IPO Year
- THAR 2022
- AYRO N/A
- Fundamental
- Price
- THAR $1.90
- AYRO $0.59
- Analyst Decision
- THAR Strong Buy
- AYRO
- Analyst Count
- THAR 1
- AYRO 0
- Target Price
- THAR $17.00
- AYRO N/A
- AVG Volume (30 Days)
- THAR 20.9K
- AYRO 223.6K
- Earning Date
- THAR 11-07-2024
- AYRO 03-31-2025
- Dividend Yield
- THAR N/A
- AYRO N/A
- EPS Growth
- THAR N/A
- AYRO N/A
- EPS
- THAR N/A
- AYRO N/A
- Revenue
- THAR N/A
- AYRO $221,671.00
- Revenue This Year
- THAR N/A
- AYRO $2,424.87
- Revenue Next Year
- THAR N/A
- AYRO N/A
- P/E Ratio
- THAR N/A
- AYRO N/A
- Revenue Growth
- THAR N/A
- AYRO N/A
- 52 Week Low
- THAR $1.84
- AYRO $0.49
- 52 Week High
- THAR $7.46
- AYRO $1.83
- Technical
- Relative Strength Index (RSI)
- THAR 43.41
- AYRO 39.78
- Support Level
- THAR $1.86
- AYRO $0.49
- Resistance Level
- THAR $1.95
- AYRO $0.85
- Average True Range (ATR)
- THAR 0.07
- AYRO 0.06
- MACD
- THAR -0.00
- AYRO -0.00
- Stochastic Oscillator
- THAR 16.33
- AYRO 28.33
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About AYRO AYRO Inc.
AYRO Inc design and manufacture compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, which is the design, development, manufacturing, and sales of electric vehicles, and operates in the United States.